Cited by 93Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatmentGenetic Associations and Epidemiology

A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium

Open access
Gur, R E, Bassett, A S, McDonald-McGinn, D M, Bearden, C E, Chow, E, Emanuel, B S, Owen, M, Swillen, A +7 more·2017·Molecular Psychiatry

Abstract

Rare copy number variants contribute significantly to the risk for schizophrenia, with the 22q11.2 locus consistently implicated. Individuals with the 22q11.2 deletion syndrome (22q11DS) have an estimated 25-fold increased risk for schizophrenia spectrum disorders, compared to individuals in the general population. The International 22q11DS Brain Behavior Consortium is examining this highly informative neurogenetic syndrome phenotypically and genomically. Here we detail the procedures of the effort to characterize the neuropsychiatric and neurobehavioral phenotypes associated with 22q11DS, focusing on schizophrenia and subthreshold expression of psychosis. The genomic approach includes a combination of whole-genome sequencing and genome-wide microarray technologies, allowing the investigation of all possible DNA variation and gene pathways influencing the schizophrenia-relevant phenotypic expression. A phenotypically rich data set provides a psychiatrically well-characterized sample of unprecedented size (n=1616) that informs the neurobehavioral developmental course of 22q11DS. This combined set of phenotypic and genomic data will enable hypothesis testing to elucidate the mechanisms underlying the pathogenesis of schizophrenia spectrum disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2017.161

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The International Brain Behavior Consortium has started systematically using a set of dimensional psychopathology measures across several genetic disorders, especially high-risk CNVs.

    “For instance, the International Brain Behavior Consortium (IBBC) has begun to apply a battery of dimensional measures of psychopathology systematically across multiple genetic disorders (Gur et al., 2017), with a particular focus on CNVs that carry significant risk.”

    From Getting to the cores of autism (2019) · cites this paper as Gur et al., 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [64]First MB Spitzer RL Gibbon M Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition Biometrics Research New York State Psychiatric Institute New York 2002
  2. [67]McGorry PD Singh B Schizophrenia: risk and possibility Burrows G Handbook of Studies on Preventive Psychiatry Elsevier Amsterdam 1995 491 514

Cited by

Sorted by citations

Authors
Gur, R. E., Bassett, A. S., McDonald-McGinn, D. M., Bearden, C. E., Chow, E., Emanuel, B. S., Owen, M., Swillen, A., Van den Bree, M., Vermeesch, J., Vorstman, J. A. S., Warren, S., Lehner, T., Morrow, B., & and The International 22q11.2 Deletion Syndrome Brain Behavior Consortium
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Centre for Addiction and Mental Health (CA)
  • University of California, Los Angeles (US)
  • Cardiff University (GB)
  • KU Leuven (BE)
  • University Medical Center Utrecht (NL)
  • Emory University (US)
  • National Institute of Mental Health (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Gur, R E
Venue
Molecular Psychiatry
Published
2017-08-01
Volume
22
Issue
12
Pages
1664-1672
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2726119716
Cited by
93
References
103
Citations by year
2026: 9 · 2025: 8 · 2024: 12 · 2023: 6 · 2022: 11 · 2021: 15 · 2020: 10 · 2019: 11 · 2018: 11
FWCI
5.79
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion)
Funders
  • Wellcome Trust (110222/Z/15/Z)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (144260, 324730)
  • National Institutes of Health (UL1TR000454, UL1TR002378)
  • Medical Research Council (MR/L010305/1)
  • National Institute of Mental Health (U01MH101723, U01MH101719, U01MH087626, L30 MH111007, U01MH087636, U01MH101724, R01MH085953, R01MH064824, U01MH101720, U01MH101722, R37MH085953)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD079125, P01HD070454)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
22q11.2 deletion syndrome, schizophrenia spectrum disorders, copy number variation, neuropsychiatric phenotypes, neurobehavioral phenotype, schizophrenia pathogenesis, whole genome sequencing, developmental course
MeSH terms
Scholarly Communication, Adolescent, Adult, Aged, Child, Cooperative Behavior, DiGeorge Syndrome, Female, Humans, Male, Middle Aged, Models, Genetic, Models, Neurological, Phenotype, Schizophrenia, Cohort Studies, Genome, Genetic Predisposition to Disease, Young Adult, DNA Copy Number Variations, Data Mining

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review